D.E. Shaw & Co
SEM

D.E. Shaw & Co’s Select Medical SEM Stock Holding History

D.E. Shaw & Co’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-42,874
Closed -$333K – 3963
2014
Q4 		$333K Hold
42,874
– – ﹤0.01% 3591
2014
Q3 		$278K Buy
+42,874
New +$331K ﹤0.01% 3729

Other funds holding SEM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

D.E. Shaw & Co's SEM Position: Q2 2026 in Review

D.E. Shaw & Co reduced its Select Medical (SEM) stake by 41% in Q2 2026, selling an estimated $9.27M and leaving 798,290 shares worth $13.2M. The position accounts for 0.01% of the portfolio, ranked #1606.

D.E. Shaw & Co first reported a position in SEM in Q2 2013 and has held it in 47 quarters since. The position peaked at $32.8M in Q4 2025. 242 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • D.E. Shaw & Co held 798,290 shares of Select Medical worth $13.2M as of Q2 2026.
  • D.E. Shaw & Co sold 562,635 Select Medical shares in Q2 2026, an estimated $9.27M.
  • Select Medical made up 0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #1606 holding.
  • D.E. Shaw & Co first reported a position in Select Medical in Q2 2013 and has held it in 47 quarters since.
  • D.E. Shaw & Co's Select Medical position peaked at $32.8M in Q4 2025.
  • 242 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.